http://www.geneuro.com/fr/patients-fr/francais
The GNC-501 study, titled “Temelimab as a Disease Modifying Therapy in Patients with Neurological, Neuropsychological, and Psychiatric Symptoms in Post-COVID-19 or Post-Acute Sequelae of COVID-19 (PASC) Syndrome,” will enroll 200 patients from...
Severe Neuro-COVID is associated with peripheral immune signatures, autoimmunity and neurodegeneration: a prospective cross-sectional study
Etter MM, Martins TA, Kulsvehagen L, Pössnecker E, Duchemin W, Hogan S, Sanabria-Diaz G, Müller J, Chiappini A, Rychen J, Eberhard N, Guzman R, Mariani L...
Increasing evidence suggests persistent cognitive dysfunction after COVID-19. In this cross-sectional study, frontal lobe function was assessed 12 months after the acute phase of the disease, using tailored eye tracking assessments.
Individuals who recovered from COVID-19 made significantly...
Mindfulness Meditation Interventions for Long COVID: Biobehavioral Gene Expression and Neuroimmune Functioning
Nicole Porter *, Leonard A Jason *
Center for Community Research, DePaul University, Chicago, IL, USA
*These authors contributed equally to this work
Abstract:
Some individuals...
Abstract
Similar to previous pandemics, COVID-19 has been succeeded by well-documented post-infectious sequelae, including chronic fatigue, cough, shortness of breath, myalgia, and concentration difficulties, which may last 5 to 12 weeks or longer after the acute phase of illness.
Both the...
[note: I just got this via a Medscape alert, I have not read it yet, just grabbed a few sections for the quote below]
Do Fatigue and Exercise Intolerance Post-COVID-19 Indicate a Chronic Disease?
Authors: News Author: Miriam E. Tucker; CME Author: Charles P. Vega, MDFaculty and Disclosures
CME...
Abstract
Background
Brain 18F-FDG PET imaging has the potential to provide an objective assessment of brain involvement in post-COVID-19 conditions but previous studies of heterogeneous patient series yield inconsistent results. The current study aimed to investigate brain 18F-FDG PET findings...
Patients who recovered from the novel coronavirus disease 2019 (COVID-19) may experience a range of long-term symptoms. Since the lung is the most common site of the infection, pulmonary sequelae may present persistently in COVID-19 survivors.
To better understand the symptoms associated with...
I found out by accident some time ago that my award has been extended. I needed an up-to-date award letter to renew my Blue Badge, and when they sent it I noticed that the end date was nine months later than it had been. Today I actually got a notification of it.
It's happened because they...
Abstract
Fatigue is a dominant feature of both acute and convalescent coronavirus disease 2019 (COVID-19) (sometimes termed “long-COVID”), with up to 46% of patients reporting fatigue that lasts from weeks to months. The investigators of the international Collaborative on Fatigue Following...
Full title:
Assessment of Adult Patients with Long COVID Manifestations Suspected as Cardiovascular: A Single-Center Experience
Abstract
Background: Persistent symptoms affect a subset of coronavirus disease 2019 (COVID-19) survivors. Some of these may be cardiovascular (CV)-related...
The RECOVER Initiative is doing a trial on Paxlovid for long Covid. Here's the listing on ClinicalTrials.gov:
SARS CoV-2 Viral Persistence Study (PASC) - Study of Long COVID-19 (PASC)
Highlights:
Double-blind multi-center trial in the US
1700 participants
They'll take the drug for 15 days...
Key Points
Question How common are COVID-19 symptoms lasting longer than 2 months, also known as long COVID, among adults in the United States, and which adults are most likely to experience long COVID?
Findings In this cross-sectional study of more than 16 000 individuals, 15% of US adults...
The LC survival guide is a a peer-to-peer advice book, edited by Fiona Lowenstein.
https://theexperimentpublishing.com/catalogs/fall-2022/long-covid-survival-guide/
Events will take place for its release (one of which will be hosted by @dave30th )
Objective: An alarming proportion (>30%) of patients affected by SARS-CoV-2 (COVID-19) continue to experience neurological symptoms, including headache, dizziness, smell and/or taste abnormalities, and impaired consciousness (brain fog), after recovery from the acute infection. These symptoms...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.